Smart Talk: Clinical trials; Battle of Brandywine
What to look for on Smart Talk Friday, March 20. 2015:
Clinical cancer trials can be a very effective option for patients, yet very few participate in those that are available. Clinical trials are research studies that evaluate new approaches to screen for, diagnose, treat and prevent cancer. Every year, there are 1.5 million new cancer diagnoses in the United States. Of these new patients, some 200,000 are eligible for clinical trials, but only one-third of the potential patients enroll.
The Fox Chase Cancer Center of the Temple University Health System is in the midst of its Be the Breakthrough campaign designed to bring attention to clinical trials.
On Friday’s Smart Talk discuss how useful clinical trials can be in fighting cancer and why more patients don’t participate.
Appearing on the program are Dr. Margaret von Mehren, Director of Sarcoma Oncology, Director of Clinical Trials Operations and Associate Director for Clinical Research at Fox Chase Cancer Center, Dr. Robert Rice, lead medical oncologist at Wellspan Medical Oncology, and Mark Wilson, a cancer survivor who personally benefitted from a clinical trial.
The Battle of Brandywine was fought in southern Chester County on September 11, 1777 during the Revolutionary War. It was the largest battle of the Revolution and even though British
forces defeated the Continental Army, it may have saved the American cause.
So writes another guest on Friday’s program — Michael C. Harris, author of the book Brandywine: A Military History of the Battle that Lost Philadelphia but Saved America.
